Pioneering Rare Disease Clinical Research Solutions

Recruitment for rare disease clinical trials generally requires cross-border recruitment and multiple sites, underscoring the need for strong project management and site management capabilities. Ergomed’s services include locating hard-to-find patients worldwide, and our teams operate globally, providing seamless support across time zones and countries to meet client needs. We are recognized experts in rare disease research, with 70% of our project managers and 80% of our Clinical Research Associates (CRAs) possessing experience in rare diseases. This deep expertise allows us to support complex clinical programs effectively, from site management and study physician support to patient engagement.

Around half of the rare disease patient population are children and teenagers. Conducting research in this demographic requires specialized expertise. Ergomed’s unique family-centric approach addresses these young patients’ medical needs and recognizes their families’ crucial role in their care. We emphasize the positive impact on the lives of patients with rare diseases and their families, providing a sense of reassurance and understanding. Our research teams, backed by the knowledge and expertise of our Patient Engagement Team, put patients and their families first.

Drug development in rare diseases often involves advanced therapy medicinal products, including cell and gene therapy products. These therapies introduce additional layers of complexity and challenges in clinical trials. We collaborate with physicians to design studies and develop operational strategies that support complex clinical trials. Ergomed’s site management model, combined with our extensive experience in rare disease trials, enables us to effectively recruit patients, maintain a secure chain of custody for treatments and sample collections, ensure close safety monitoring, and collect high-quality data.

At Ergomed, our commitment to pioneering rare disease clinical research solutions is unwavering. It is this dedication that drives us to improve the lives of patients and their families. With our global reach, expert teams, and innovative approaches to advanced therapies, we are uniquely positioned to navigate the complexities of rare disease trials. Our patient-centric philosophy, extensive experience, and robust project management capabilities ensure we deliver exceptional support and high-quality outcomes for our clients. Join us in our mission to advance rare disease research and make a meaningful impact on the future of healthcare.